| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cognition Therapeutics Inc (CGTX) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. CGTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $1.23M | - | |
| Other | 528.3K | $641.9K | - | |
| CFO | 455.4K | $553.3K | - | |
| Dir | 86.5K | $105.1K | - | |
| Dir | 58.5K | $71.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 2021 | O'Brien James Michael | Chief Financial Officer | Buy | 5,000 | $12.00 | $60,000.00 | New | -43.4% | -85.1% |